Episode notes
In this episode of WHV Insider, Steve Moore is joined by Dr Wareed Alenaini, Founder and CEO of Twinn Health, for a practical conversation about AI-driven early detection, preventative health, and what it takes to build a health technology company across both the UK and Saudi Arabia.
Twinn Health began as research at Imperial College London, where Dr Alenaini studied how MRI data reveals patterns of disease progression. That work became a patented, NHS-validated platform that applies AI to identify chronic and age-related conditions years before clinical symptoms appear. Having commercialised in the UK, the company is now entering the Saudi market, and the conversation is candid about how different those two journeys have been.
One of the most instructive parts of the discussion is what happened when the same product met two very different systems. In the UK, the private MRI market had a problem with underutilised capacity, and Twinn offered a way to fill it. In Saudi Arabia, the position was reversed: scanners are fully utilised, some centres run twenty-four hour cycles, and new machines are added year after year. The technology did not change, but the value proposition had to be rebuilt entirely, around insurers who own the hospitals and the machines, and who stand to capture the savings that earlier detection creates.
That experience speaks to a core theme behind WHV Insider: Saudi Arabia is not simply a market to enter, but an ecosystem to understand. Desk research and published data can suggest a strong fit while the commercial reality on the ground looks nothing like it. As Dr Alenaini puts it, the insight that mattered came from knocking on doors and speaking directly to customers.
In this episode, we cover:
- How AI and MRI data are being used to detect chronic disease before symptoms appear
- Why a value proposition that works in the UK can fail on arrival in Saudi Arabia
- Saudi Arabia's diagnostic infrastructure and where early detection technology fits
- The chronic disease burden shaping health priorities across the Kingdom
- Why non-communicable conditions are driven far more by environment than by willpower
- Vision 2030 at ten years, and the shift from extending lifespan to extending healthspan
- Why Saudi's cluster model borrows selectively rather than copying any single system
- The university hospital route into the Saudi system that many market entry plans overlook
- Practical guidance for non-Saudi founders on building trust in a relationship-led market
- What still gets misunderstood about Saudi Arabia from the outside
- Lessons from taking a university spinout through validation, clearance and commercialisation
Dr Alenaini also reflects on the personal experience of late diagnosis within her own family that shaped the company's founding purpose, and shares the advice from a mentor that has stayed with her throughout: never be afraid of making mistakes, but never make the same mistake twice.
For founders, investors, clinicians and healthcare leaders looking at Saudi Arabia and the wider GCC, this episode offers a grounded view of where the opportunity in preventative health sits — and why building the right commercial model for the local system matters as much as having the right technology.
Find Dr Wareed Alenaini and Twinn Health at twinn.health or on LinkedIn.